BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 34163251)

  • 1. microRNA-944 Inhibits the Malignancy of Hepatocellular Carcinoma by Directly Targeting IGF-1R and Deactivating the PI3K/Akt Signaling Pathway [Retraction].
    Cancer Manag Res; 2021; 13():4765. PubMed ID: 34163251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. microRNA-944 inhibits the malignancy of hepatocellular carcinoma by directly targeting IGF-1R and deactivating the PI3K/Akt signaling pathway.
    Lv L; Wang X; Ma T
    Cancer Manag Res; 2019; 11():2531-2543. PubMed ID: 31114322
    [No Abstract]   [Full Text] [Related]  

  • 3. microRNA-532 suppresses the PI3K/Akt signaling pathway to inhibit colorectal cancer progression by directly targeting IGF-1R [Retraction].
    Am J Cancer Res; 2021; 11(9):4641. PubMed ID: 34659912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-761 Targets FGFR1 to Suppress the Malignancy of Osteosarcoma by Deactivating PI3K/Akt Pathway [Retraction].
    Onco Targets Ther; 2021; 14():4937-4938. PubMed ID: 34611413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. microRNA-877 Inhibits Malignant Progression of Colorectal Cancer by Directly Targeting MTDH and Regulating the PTEN/Akt Pathway [Retraction].
    Cancer Manag Res; 2021; 13():7489-7490. PubMed ID: 34611442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-Induced Aquaporin-3 Changes Hepatocellular Carcinoma Cell Sensitivity to Sorafenib by Activating the PI3K/Akt Signaling Pathway [Retraction].
    Cancer Manag Res; 2021; 13():9027-9028. PubMed ID: 34916846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. microRNA-605 Directly Targets SOX9 to Alleviate the Aggressive Phenotypes of Glioblastoma Multiforme Cell Lines by Deactivating the PI3K/Akt Pathway [Retraction].
    Onco Targets Ther; 2021; 14():4739-4740. PubMed ID: 34526778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. microRNA-628 Inhibits the Proliferation of Acute Myeloid Leukemia Cells by Directly Targeting IGF-1R [Retraction].
    Onco Targets Ther; 2021; 14():4847-4848. PubMed ID: 34584423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long Non-Coding RNA
    Cancer Manag Res; 2022; 14():399-400. PubMed ID: 35115836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. microRNA-548b Suppresses Aggressive Phenotypes of Hepatocellular Carcinoma by Directly Targeting High-Mobility Group Box 1 mRNA [Retraction].
    Cancer Manag Res; 2021; 13():7593-7594. PubMed ID: 34675654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-936 Targets FGF2 to Inhibit Epithelial Ovarian Cancer Aggressiveness by Deactivating the PI3K/Akt Pathway [Retraction].
    Onco Targets Ther; 2021; 14():4961-4962. PubMed ID: 34675537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-665 Inhibits the Oncogenicity of Retinoblastoma by Directly Targeting High-Mobility Group Box 1 and Inactivating the Wnt/β-Catenin Pathway [Retraction].
    Cancer Manag Res; 2021; 13():7245-7246. PubMed ID: 34566431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. microRNA-26a Directly Targeting MMP14 and MMP16 Inhibits the Cancer Cell Proliferation, Migration and Invasion in Cutaneous Squamous Cell Carcinoma [Retraction].
    Cancer Manag Res; 2021; 13():7249-7250. PubMed ID: 34566433
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Cancer Manag Res; 2021; 13():7645-7646. PubMed ID: 34675660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of MicroRNA-130a Inhibits Oral Squamous Cell Carcinoma Proliferation and Metastasis via the Hippo-YAP Pathway [Retraction].
    Cancer Manag Res; 2021; 13():8005-8006. PubMed ID: 34707407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-876 is Sponged by Long Noncoding RNA LINC00707 and Directly Targets Metadherin to Inhibit Breast Cancer Malignancy [Retraction].
    Cancer Manag Res; 2021; 13():7243-7244. PubMed ID: 34566430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-503 Inhibits Non-Small Cell Lung Cancer Progression by Targeting PDK1/PI3K/AKT Pathway [Retraction].
    Onco Targets Ther; 2023; 16():1023-1024. PubMed ID: 38090112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retraction: Down-regulation of HOXB5 inhibits TGF-β-induced migration and invasion in hepatocellular carcinoma cells
    Sun JP; Ge QX; Ren Z; Sun XF; Xie SP
    RSC Adv; 2022 Sep; 12(43):27996. PubMed ID: 36320248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retraction: Kannan et al. AEG-1/miR-221 Axis Cooperatively Regulates the Progression of Hepatocellular Carcinoma by Targeting PTEN/PI3K/AKT Signaling Pathway.
    International Journal Of Molecular Sciences Editorial Office
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35708348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.